1. Home
  2. XERS vs LQDT Comparison

XERS vs LQDT Comparison

Compare XERS & LQDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XERS
  • LQDT
  • Stock Information
  • Founded
  • XERS 2005
  • LQDT 1999
  • Country
  • XERS United States
  • LQDT United States
  • Employees
  • XERS N/A
  • LQDT N/A
  • Industry
  • XERS Biotechnology: Pharmaceutical Preparations
  • LQDT Catalog/Specialty Distribution
  • Sector
  • XERS Health Care
  • LQDT Consumer Discretionary
  • Exchange
  • XERS Nasdaq
  • LQDT Nasdaq
  • Market Cap
  • XERS 752.7M
  • LQDT 773.6M
  • IPO Year
  • XERS 2018
  • LQDT 2006
  • Fundamental
  • Price
  • XERS $5.29
  • LQDT $24.34
  • Analyst Decision
  • XERS Strong Buy
  • LQDT Strong Buy
  • Analyst Count
  • XERS 6
  • LQDT 2
  • Target Price
  • XERS $6.25
  • LQDT $38.50
  • AVG Volume (30 Days)
  • XERS 2.2M
  • LQDT 263.3K
  • Earning Date
  • XERS 08-07-2025
  • LQDT 08-07-2025
  • Dividend Yield
  • XERS N/A
  • LQDT N/A
  • EPS Growth
  • XERS N/A
  • LQDT 23.09
  • EPS
  • XERS N/A
  • LQDT 0.79
  • Revenue
  • XERS $222,551,000.00
  • LQDT $439,246,000.00
  • Revenue This Year
  • XERS $35.03
  • LQDT $35.02
  • Revenue Next Year
  • XERS $18.31
  • LQDT $9.90
  • P/E Ratio
  • XERS N/A
  • LQDT $30.82
  • Revenue Growth
  • XERS 29.88
  • LQDT 35.78
  • 52 Week Low
  • XERS $2.10
  • LQDT $19.87
  • 52 Week High
  • XERS $6.07
  • LQDT $39.72
  • Technical
  • Relative Strength Index (RSI)
  • XERS 62.91
  • LQDT 50.93
  • Support Level
  • XERS $5.00
  • LQDT $23.73
  • Resistance Level
  • XERS $5.49
  • LQDT $24.71
  • Average True Range (ATR)
  • XERS 0.24
  • LQDT 0.57
  • MACD
  • XERS 0.08
  • LQDT 0.16
  • Stochastic Oscillator
  • XERS 79.38
  • LQDT 79.67

About XERS Xeris Biopharma Holdings Inc.

Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).

About LQDT Liquidity Services Inc.

Liquidity Services Inc is an online auction marketplace. It manages and sells inventory and equipment for business and government clients by operating a network of e-commerce marketplaces that enable buyers and sellers to transact in an efficient, automated environment offering across different product categories. The company has four reportable segments: GovDeals, Capital Assets Group (CAG), Retail Supply Chain Group (RSCG), and Machinio. It generates majority of its revenue from Retail Supply Chain Group (RSCG) segment which consists of marketplaces that enable corporations located in the United States and Canada to sell excess, returned, and overstocked consumer goods. Geographically, a substantial portion the company's revenue is generated from its business in United States.

Share on Social Networks: